Ever Source Wealth Advisors, LLC Syndax Pharmaceuticals Inc Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 63 shares of SNDX stock, worth $854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63Holding current value
$854% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding SNDX
# of Institutions
232Shares Held
92.7MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$116 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$107 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$80.7 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.31MShares$72 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$66.2 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $767M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...